GenSight Biologics S.A. (LON:0RIM)

GenSight Biologics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	29	27	22	138	214	273
Market Cap Growth	22.73%	22.73%	-83.82%	-35.82%	-21.34%	296.62%
Enterprise Value	44	40	40	131	185	272
Last Close Price	0.20	0.23	0.40	2.98	4.69	6.13
PS Ratio	13.55	12.59	8.66	31.90	33.13	40.91
PB Ratio	-1.32	-1.23	-0.84	-10.16	15.97	25.91
P/TBV Ratio	-	-	-	-	16.09	26.20
EV/Sales Ratio	19.47	18.59	15.53	30.25	28.53	40.80
Debt / Equity Ratio	-0.71	-0.71	-0.77	-1.17	1.10	1.63
Asset Turnover	0.26	0.26	0.17	0.12	0.15	0.19
Quick Ratio	0.20	0.20	0.18	0.96	2.18	2.41
Current Ratio	0.24	0.24	0.26	1.57	2.40	2.56
Return on Equity (ROE)	-	-	-	-7781.69%	-206.34%	-305.52%
Return on Assets (ROA)	-99.39%	-99.39%	-105.83%	-42.13%	-33.80%	-39.03%
Return on Capital (ROIC)	-	-	-	-96.45%	-54.62%	-59.68%
Earnings Yield	-39.35%	-42.36%	-102.16%	-17.80%	-11.21%	-11.18%
FCF Yield	-36.36%	-39.14%	-96.14%	-21.91%	-6.72%	-4.95%
Buyback Yield / Dilution	-98.18%	-98.18%	-4.29%	-2.61%	-28.54%	-23.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.